Novartis Ag (NVS) Current Leases (2018 - 2025)
Historic Current Leases for Novartis Ag (NVS) over the last 7 years, with Q4 2025 value amounting to $1.7 billion.
- Novartis Ag's Current Leases rose 567.6% to $1.7 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.7 billion, marking a year-over-year increase of 567.6%. This contributed to the annual value of $1.7 billion for FY2025, which is 567.6% up from last year.
- According to the latest figures from Q4 2025, Novartis Ag's Current Leases is $1.7 billion, which was up 567.6% from $1.6 billion recorded in Q3 2025.
- Over the past 5 years, Novartis Ag's Current Leases peaked at $1.7 billion during Q2 2021, and registered a low of $275.0 million during Q4 2021.
- In the last 5 years, Novartis Ag's Current Leases had a median value of $1.6 billion in 2022 and averaged $1.5 billion.
- As far as peak fluctuations go, Novartis Ag's Current Leases tumbled by 8400.23% in 2021, and later soared by 45927.27% in 2022.
- Quarter analysis of 5 years shows Novartis Ag's Current Leases stood at $275.0 million in 2021, then surged by 459.27% to $1.5 billion in 2022, then rose by 3.9% to $1.6 billion in 2023, then decreased by 1.88% to $1.6 billion in 2024, then grew by 5.68% to $1.7 billion in 2025.
- Its Current Leases was $1.7 billion in Q4 2025, compared to $1.6 billion in Q3 2025 and $1.6 billion in Q2 2025.